Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 126

1.

The histopathologic and molecular basis for the diagnosis of histiocytic sarcoma and histiocyte-associated lymphoma of mice.

Hao X, Fredrickson TN, Chattopadhyay SK, Han W, Qi CF, Wang Z, Ward JM, Hartley JW, Morse HC 3rd.

Vet Pathol. 2010 May;47(3):434-45. doi: 10.1177/0300985810363705.

2.

Anaplastic plasmacytomas: relationships to normal memory B cells and plasma cell neoplasms of immunodeficient and autoimmune mice.

Qi CF, Shin DM, Li Z, Wang H, Feng J, Hartley JW, Fredrickson TN, Kovalchuk AL, Morse HC 3rd.

J Pathol. 2010 May;221(1):106-16. doi: 10.1002/path.2692.

3.

Citrobacter-induced colitis in mice with murine acquired immunodeficiency syndrome.

Fredrickson TN, Hartley JW, Morse HC 3rd.

Vet Pathol. 2010 Mar;47(2):312-7. doi: 10.1177/0300985809358605. Epub 2010 Jan 29.

4.

Irradiated Blm-deficient mice are a highly tumor prone model for analysis of a broad spectrum of hematologic malignancies.

Warren M, Chung YJ, Howat WJ, Harrison H, McGinnis R, Hao X, McCafferty J, Fredrickson TN, Bradley A, Morse HC 3rd.

Leuk Res. 2010 Feb;34(2):210-20. doi: 10.1016/j.leukres.2009.06.007. Epub 2009 Aug 25.

5.

Anaplastic, plasmablastic, and plasmacytic plasmacytomas of mice: relationships to human plasma cell neoplasms and late-stage differentiation of normal B cells.

Qi CF, Zhou JX, Lee CH, Naghashfar Z, Xiang S, Kovalchuk AL, Fredrickson TN, Hartley JW, Roopenian DC, Davidson WF, Janz S, Morse HC 3rd.

Cancer Res. 2007 Mar 15;67(6):2439-47.

6.

Histologic and molecular characterizations of megakaryocytic leukemia in mice.

Hao X, Shin MS, Zhou JX, Lee CH, Qi CF, Naghashfar Z, Hartley JW, Fredrickson TN, Ward JM, Morse HC 3rd.

Leuk Res. 2006 Apr;30(4):397-406. Epub 2005 Oct 10.

PMID:
16219351
7.

Expression of the cyclin-dependent kinase inhibitor p27 and its deregulation in mouse B cell lymphomas.

Qi CF, Xiang S, Shin MS, Hao X, Lee CH, Zhou JX, Torrey TA, Hartley JW, Fredrickson TN, Morse HC 3rd.

Leuk Res. 2006 Feb;30(2):153-63. Epub 2005 Aug 24.

PMID:
16122798
8.

High-throughput retroviral tagging for identification of genes involved in initiation and progression of mouse splenic marginal zone lymphomas.

Shin MS, Fredrickson TN, Hartley JW, Suzuki T, Akagi K, Morse HC 3rd.

Cancer Res. 2004 Jul 1;64(13):4419-27. Erratum in: Cancer Res. 2006 Mar 15;66(6):3345. Agaki, Keiko [corrected to Akagi, Keiko].

9.

B lymphoid neoplasms of mice: characteristics of naturally occurring and engineered diseases and relationships to human disorders.

Morse HC 3rd, McCarty T, Qi CF, Torrey TA, Naghashfar Z, Chattopadhyay SK, Fredrickson TN, Hartley JW.

Adv Immunol. 2003;81:97-121. Review. No abstract available.

PMID:
14711054
10.

Bethesda proposals for classification of lymphoid neoplasms in mice.

Morse HC 3rd, Anver MR, Fredrickson TN, Haines DC, Harris AW, Harris NL, Jaffe ES, Kogan SC, MacLennan IC, Pattengale PK, Ward JM; Hematopathology subcommittee of the Mouse Models of Human Cancers Consortium.

Blood. 2002 Jul 1;100(1):246-58.

PMID:
12070034
11.

Bethesda proposals for classification of nonlymphoid hematopoietic neoplasms in mice.

Kogan SC, Ward JM, Anver MR, Berman JJ, Brayton C, Cardiff RD, Carter JS, de Coronado S, Downing JR, Fredrickson TN, Haines DC, Harris AW, Harris NL, Hiai H, Jaffe ES, MacLennan IC, Pandolfi PP, Pattengale PK, Perkins AS, Simpson RM, Tuttle MS, Wong JF, Morse HC 3rd; Hematopathology subcommittee of the Mouse Models of Human Cancers Consortium.

Blood. 2002 Jul 1;100(1):238-45.

PMID:
12070033
12.

Combined histologic and molecular features reveal previously unappreciated subsets of lymphoma in AKXD recombinant inbred mice.

Morse HC 3rd, Qi CF, Chattopadhyay SK, Hori M, Taddesse-Heath L, Ozato K, Hartley JW, Taylor BA, Ward JM, Jenkins NA, Copeland NG, Fredrickson TN.

Leuk Res. 2001 Aug;25(8):719-33.

PMID:
11397479
13.

Non-Hodgkin lymphomas of mice.

Hori M, Xiang S, Qi CF, Chattopadhyay SK, Fredrickson TN, Hartley JW, Kovalchuk AL, Bornkamm GW, Janz S, Copeland NG, Jenkins NA, Ward JM, Morse HC 3rd.

Blood Cells Mol Dis. 2001 Jan-Feb;27(1):217-22.

PMID:
11358382
14.

Cells of the marginal zone--origins, function and neoplasia.

Morse HC 3rd, Kearney JF, Isaacson PG, Carroll M, Fredrickson TN, Jaffe ES.

Leuk Res. 2001 Feb;25(2):169-78.

PMID:
11166833
15.

Diffuse large-cell and "true" histiocytic lymphomas of mice.

Qi CF, Hori M, Taddesse-Heath L, Jenkins NA, Copeland NG, Shen H, Torrey TA, Hartley JW, Chattopadhyay SK, Fredrickson TN, Morse HC.

Curr Top Microbiol Immunol. 2000;252:301-5. Review. No abstract available.

PMID:
11125488
16.

Accelerated appearance of multiple B cell lymphoma types in NFS/N mice congenic for ecotropic murine leukemia viruses.

Hartley JW, Chattopadhyay SK, Lander MR, Taddesse-Heath L, Naghashfar Z, Morse HC 3rd, Fredrickson TN.

Lab Invest. 2000 Feb;80(2):159-69.

17.

Novel aspects of murine B cell lymphomas.

Morse HC 3rd, Qi CF, Tadesse-Heath L, Chattopadhyay SK, Ward JM, Coleman A, Hartley JW, Fredrickson TN.

Curr Top Microbiol Immunol. 1999;246:249-55. No abstract available.

PMID:
10396063
18.

Splenic marginal zone lymphomas of mice.

Fredrickson TN, Lennert K, Chattopadhyay SK, Morse HC 3rd, Hartley JW.

Am J Pathol. 1999 Mar;154(3):805-12.

19.

Expression of cyclin D1 in mouse B cell lymphomas of different histologic types and differentiation stages.

Qi CF, Chattopadhyay SK, Lander M, Kim Y, Fredrickson TN, Hartley JW, Morse HC 3rd.

Leuk Res. 1998 May;22(5):395-404.

PMID:
9652725
20.

Spontaneous development of plasmacytoid tumors in mice with defective Fas-Fas ligand interactions.

Davidson WF, Giese T, Fredrickson TN.

J Exp Med. 1998 Jun 1;187(11):1825-38.

21.

Murine cytomegalovirus infection-induced polyclonal B cell activation is independent of CD4+ T cells and CD40.

Karupiah G, Sacks TE, Klinman DM, Fredrickson TN, Hartley JW, Chen JH, Morse HC 3rd.

Virology. 1998 Jan 5;240(1):12-26.

22.

Characteristics of a murine gammaherpesvirus infection immunocompromised mice.

Kulkarni AB, Holmes KL, Fredrickson TN, Hartley JW, Morse HC 3rd.

In Vivo. 1997 Jul-Aug;11(4):281-91.

PMID:
9292294
23.

Immunologic havoc induced by the 60 kD Gag protein of the MAIDS defective virus.

Morse HC 3rd, Morawetz RA, Giese NA, Chattopadhyay SK, Tang Y, Fredrickson TN, Hartley JW.

Leukemia. 1997 Apr;11 Suppl 3:167-9.

PMID:
9209332
24.

Charlotte Friend Memorial Lecture: murine leukemia virus (MuLV) tumorigenesis.

Hartley JW, Chattopadhyay SK, Morse HC 3rd, Fredrickson TN.

Leukemia. 1997 Apr;11 Suppl 3:147-8.

PMID:
9209325
25.

Control of immunodeficiency and lymphoproliferation in mouse AIDS: studies of mice deficient in CD8+ T cells or perforin.

Tang Y, Hügin AW, Giese NA, Gabriele L, Chattopadhyay SK, Fredrickson TN, Kägi D, Hartley JW, Morse HC 3rd.

J Virol. 1997 Mar;71(3):1808-13.

26.

Endogenous Mtv-encoded superantigens are not required for development of murine AIDS.

McCarty TC, Chattopadhyay SK, Scherer MT, Fredrickson TN, Hartley JW, Morse HC 3rd.

J Virol. 1996 Nov;70(11):8148-50.

27.

In vivo murine tumor gene delivery and expression by systemic recombinant vaccinia virus encoding interleukin-1beta.

Peplinski GR, Tsung AK, Casey MJ, Meko JB, Fredrickson TN, Buller RM, Norton JA.

Cancer J Sci Am. 1996 Jan-Feb;2(1):21-7.

PMID:
9166494
28.

Classification of mouse lymphomas.

Fredrickson TN, Hartley JW, Morse HC 3rd, Chattopadhyay SK, Lennert K.

Curr Top Microbiol Immunol. 1995;194:109-16. No abstract available.

PMID:
7895485
29.

Clonal outgrowths of T and B cells in SCID mice reconstituted with cells from mice with MAIDS.

Tang Y, Chattopadhyay SK, Hartley JW, Fredrickson TN, Morse HC 3rd.

In Vivo. 1994 Nov-Dec;8(6):953-9.

PMID:
7772747
30.

Influence of H-2 class II antigens on the development of murine AIDS.

Makino M, Tang Y, Murphy DB, Fredrickson TN, Okada Y, Fujiwara M, Chattopadhyay SK, Mizuochi T, Komuro K, Morse HC 3rd, et al.

J Immunol. 1994 Apr 15;152(8):4157-64.

PMID:
8144977
31.

Importance of interferons in recovery from mousepox.

Karupiah G, Fredrickson TN, Holmes KL, Khairallah LH, Buller RM.

J Virol. 1993 Jul;67(7):4214-26.

32.

Early divergence of erythroid lineage suggested by gene rearrangements in mouse hematopoietic neoplasms.

Fredrickson TN, Hartley JW, Morse HC 3rd.

Exp Hematol. 1993 Feb;21(2):354-7.

PMID:
8425572
33.

Effects of immunization with the p12 proteins of LP-BM5 defective and ecotropic viruses on development of MAIDS.

Tang Y, Hügin AW, Hartley JW, Fredrickson TN, Morse HC 3rd, Chattopadhyay SK.

Arch Virol. 1993;129(1-4):155-66.

PMID:
8385912
34.

Retrovirus-induced lymphoproliferation as a model for developing diagnostic criteria for malignant lymphoma in mice.

Fredrickson TN, Tang Y, Chattopadhyay SK, Morse HC 3rd, Hartley JW.

Toxicol Pathol. 1993;21(2):219-28.

PMID:
8210944
35.

Thrombocytopenia in a retrovirally-induced murine erythroleukemia.

Gamba-Vitalo C, Lobue J, Fredrickson TN, Ien SM, Pedersen J, Gordon AS, Pincus MR.

Ann Clin Lab Sci. 1992 Nov-Dec;22(6):385-97.

PMID:
1456728
36.
37.

Retrovirus-induced immunodeficiency in the mouse: MAIDS as a model for AIDS.

Morse HC 3rd, Chattopadhyay SK, Makino M, Fredrickson TN, Hügin AW, Hartley JW.

AIDS. 1992 Jul;6(7):607-21. Review. No abstract available.

PMID:
1503680
38.

Acute inflammatory response to cowpox virus infection of the chorioallantoic membrane of the chick embryo.

Fredrickson TN, Sechler JM, Palumbo GJ, Albert J, Khairallah LH, Buller RM.

Virology. 1992 Apr;187(2):693-704.

PMID:
1312273
39.

Lymphomas in mice with retrovirus-induced immunodeficiency.

Tang Y, Fredrickson TN, Chattopadhyay SK, Hartley JW, Morse HC 3rd.

Curr Top Microbiol Immunol. 1992;182:395-8. No abstract available.

PMID:
1490377
40.

ZDV delays but does not prevent the transmission of MAIDS by LP-BM5 MuLV-infected macrophage-monocytes.

Bilello JA, Kort JJ, MacAuley C, Fredrickson TN, Yetter RA, Eiseman JL.

J Acquir Immune Defic Syndr. 1992;5(6):571-6.

PMID:
1316959
41.

Effect of 3'azidothymidine administered in drinking water or by continuous infusion on the development of MAIDS.

Eiseman JL, Yetter RA, Fredrickson TN, Shapiro SG, MacAuley C, Bilello JA.

Antiviral Res. 1991 Dec;16(4):307-26.

PMID:
1663732
42.
43.

Effects of non-MHC loci on resistance to retrovirus-induced immunodeficiency in mice.

Makino M, Davidson WF, Fredrickson TN, Hartley JW, Morse HC 3rd.

Immunogenetics. 1991;33(5-6):345-51.

PMID:
1646765
44.

H-2-associated and background genes influence the development of a murine retrovirus-induced immunodeficiency syndrome.

Makino M, Morse HC 3rd, Fredrickson TN, Hartley JW.

J Immunol. 1990 Jun 1;144(11):4347-55.

PMID:
2160500
45.

Mutation of the core or adjacent LVb elements of the Moloney murine leukemia virus enhancer alters disease specificity.

Speck NA, Renjifo B, Golemis E, Fredrickson TN, Hartley JW, Hopkins N.

Genes Dev. 1990 Feb;4(2):233-42.

46.

Use of a neonatal murine retrovirus model to evaluate the long-term efficacy and toxicity of antiviral agents.

Bilello JA, MacAuley C, Fredrickson TN, Bell MM, McKissick C, Shapiro SG, Personette R, Eiseman JL.

Ann N Y Acad Sci. 1990;616:238-51. No abstract available.

PMID:
2078021
47.

Inhibition of an inflammatory response is mediated by a 38-kDa protein of cowpox virus.

Palumbo GJ, Pickup DJ, Fredrickson TN, McIntyre LJ, Buller RM.

Virology. 1989 Sep;172(1):262-73.

PMID:
2773318
48.

Susceptibility to raf and raf/myc retroviruses is governed by different genetic loci.

Klinken SP, Hartley JW, Fredrickson TN, Rapp UR, Morse HC 3rd.

J Virol. 1989 May;63(5):2411-4.

49.
50.

Supplemental Content

Loading ...
Support Center